KOSDAQ - Delayed Quote KRW

KOLMAR BNH Co.,Ltd. (200130.KQ)

Compare
12,630.00
+230.00
+(1.85%)
At close: 3:30:16 PM GMT+9
Loading Chart for 200130.KQ
DELL
  • Previous Close 12,400.00
  • Open 0.00
  • Bid --
  • Ask --
  • Day's Range 0.00 - 0.00
  • 52 Week Range 0.00 - 19,970.00
  • Volume 0
  • Avg. Volume 91,369
  • Market Cap (intraday) 367.746B
  • Beta (5Y Monthly) 0.82
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Mar 17, 2025 - Mar 21, 2025
  • Forward Dividend & Yield 308.00 (2.35%)
  • Ex-Dividend Date Dec 27, 2023
  • 1y Target Est --

Kolmar BNH Co., Ltd. engages in the research and development of materials used in the functional health food and cosmetics market in South Korea and internationally. The company offers cosmetics; and provides total functional health food original development manufacturing services, such as manufacturing tablets, hard capsules, soft capsules, liquids, gels, powder dosage, and various new formulation forms. It offers packaging products, such as PTP/multi-PTP, powder stick/pouch, three-side cloth, four-side, and liquid stick packaging; and ODM consulting services. The company was formerly known as Sun Bio Tech and changed its name to Kolmar BNH Co., Ltd. in 2013. Kolmar BNH Co., Ltd. was founded in 2004 and is headquartered in Sejong, South Korea.

www.kolmarbnh.co.kr

512

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 200130.KQ

View More

Performance Overview: 200130.KQ

Trailing total returns as of 1/16/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

200130.KQ
9.35%
KOSPI Composite Index
5.33%

1-Year Return

200130.KQ
26.36%
KOSPI Composite Index
1.20%

3-Year Return

200130.KQ
56.25%
KOSPI Composite Index
13.50%

5-Year Return

200130.KQ
55.14%
KOSPI Composite Index
12.43%

Compare To: 200130.KQ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 200130.KQ

View More

Valuation Measures

As of 1/15/2025
  • Market Cap

    361.05B

  • Enterprise Value

    514.13B

  • Trailing P/E

    22.75

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.58

  • Price/Book (mrq)

    0.89

  • Enterprise Value/Revenue

    0.83

  • Enterprise Value/EBITDA

    10.78

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.91%

  • Return on Assets (ttm)

    2.53%

  • Return on Equity (ttm)

    4.14%

  • Revenue (ttm)

    611.19B

  • Net Income Avi to Common (ttm)

    17.77B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    74.05B

  • Total Debt/Equity (mrq)

    57.77%

  • Levered Free Cash Flow (ttm)

    -41.99B

Research Analysis: 200130.KQ

View More

People Also Watch